Relapse Treatment is a clinical intervention strategy within the domain of multiple sclerosis pharmacotherapy that specifically targets the acute management of disease exacerbations by reducing inflammation and accelerating recovery, thereby distinguishing it from progressive disease-modifying or preventive therapeutic approaches.
794
Publications
55K
Citations
5.9K
Authors
1.8K
Institutions
Publications per year
2017–2026
259
Publications
794
Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis
K. P. Johnson, Benjamin Brooks, J. A. Cohen et al. · Neurology · 1995 · 1.9K citations
Pharmacy, Neurology, Pharmacotherapy +15
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Ralf Gold, Ludwig Kappos, Douglas L. Arnold et al. · New England Journal of Medicine · 2012 · 1.7K citations · Full text
Medicine, Neurology, Pharmacotherapy +17
Two-, six-, and 12-minute walking tests in respiratory disease.
R. J. A. Butland, J. A. Pang, E R Gross et al. · BMJ · 1982 · 1.7K citations · Full text
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Ludwig Kappos, Jack P. Antel, Giancarlo Comi et al. · New England Journal of Medicine · 2006 · 1.1K citations · Full text
1–5 of 794
Authors
5.9K
- LK
22
h-index
- KS
16
h-index
- EH
16
h-index
- DLDouglas L. Arnold
Montreal Neurological Institute and Hospital, Canada
16 publications · 2.8K citations
14
h-index
- MT
13
h-index
1–5 of 5.9K
Institutions
1.8K
Cleveland Clinic
Cleveland, United States
25 h-index
100 publications
11.9K citations
University Hospital of Basel
Basel, Switzerland
19 h-index
63 publications
8.9K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
19 h-index
82 publications
2.4K citations
The University of Melbourne
Melbourne, Australia
19 h-index
81 publications
6.2K citations
Biogen (United States)
Cambridge, United States
18 h-index
100 publications
11.6K citations
University College London
London, United Kingdom
17 h-index
95 publications
8.3K citations
University of Pennsylvania
Philadelphia, United States
17 h-index
44 publications
2.2K citations
Charles University
Prague, Czechia
16 h-index
49 publications
3.5K citations
1–8 of 1.8K
Venues
- Neurology
55 publications · 9.6K citations
39
h-index
- Multiple Sclerosis Journal
MSJ · 65 publications · 3.9K citations
36
h-index
- Blood
56 publications · 2.3K citations
24
h-index
- PubMed
Repository · 38 publications · 2K citations
20
h-index
- Journal of Clinical Oncology
25 publications · 1.7K citations
18
h-index
1–5